Scaffold-free three-dimensional graft from autologous adipose-derived stem cells for large bone defect reconstruction: Clinical proof of concept

Medicine (United States)

Volumn 94, Issue 50, 2015, Pages

  Dufrane, Denis ^a   Docquier, Pierre Louis ^a   Delloye, Christian ^a   Poirel, Hélène A ^a   André, Wivine ^a   Aouassar, Najima ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; CALCIUM; CD45 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; THY 1 ANTIGEN;

ADIPOSE DERIVED STEM CELL; ADOLESCENT; ANEUPLOIDY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE DEFECT; BONE DEVELOPMENT; BONE MATRIX; BONE MINERALIZATION; BONE REMODELING; BONE STRUCTURE; BONE TRANSPLANTATION; BONE TUMOR; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; FEMALE; FORCEPS; HUMAN; IN VITRO STUDY; MALE; MORBIDITY; MORPHOMETRICS; PATHOPHYSIOLOGY; PATIENT SAFETY; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDARTHROSIS; RUPTURE; SCHOOL CHILD; SUBCUTANEOUS FAT; TETRAPLOIDY; THERAPY EFFECT; THREE DIMENSIONAL GRAFT; THREE DIMENSIONAL IMAGING; TRISOMY 7; ADIPOCYTE; BONE NEOPLASMS; CYTOLOGY; FEASIBILITY STUDY; OSTEOSARCOMA; PATHOLOGY; PROCEDURES; STEM CELL; TISSUE ENGINEERING; TISSUE SCAFFOLD;

ADIPOCYTES; ADOLESCENT; BONE NEOPLASMS; CELL DIFFERENTIATION; CHILD; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; OSTEOSARCOMA; PSEUDARTHROSIS; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84952682667     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002220     Document Type: Article

References (40)

1. Tzioupis C, Giannoudis PV. Prevalence of long-bone non-unions. Injury. 2007;38(Supp. 2):S3-S9.
2. Enneking WF, Campanacci DA. Retrieved human allografts: a clinicopathological study. J Bone Joint Surg Am. 2001;83:971-986.
3. Enneking WF, Mindell ER. Observations on massive retrieved human allografts. J Bone Joint Surg Am. 1991;73:1123-1142.
4. Delloye C, Cornu O. Incorporation of massive bone allografts: can we achieve better performance? Acta Orthop Belg. 2003;69:104-111.
5. Bus MP, Dijkstra PD, Van De Sande MA, et al. Intercalary allograft reconstructions following resection of primary bone tumors: a nationwide multicenter study. J Bone Joint Surg Am. 2014;96:e26 (1-11).
6. Dohin B, Kohler R. Masquelet's procedure and bone morphogenetic protein in congenital pseudarthrosis of the tibia in children: a case series and meta-analysis. J Child Orthop. 2012;6:297-306.
7. Sen MK, Miclau T. Autologous iliac crest bone graft: Should it still be the gold standard for treating nonunions? Injury. 2007;38(Suppl 1):S75-80.
8. Goulet JA, Senunas LE, De Silva GL, et al. Autogenous iliac crest bone graft: complications and functional assessment. Clin Orthop Relat Res. 1997;339:76-81.
9. Wientroub S, Reddi AH. Influence of irradiation on the osteoinductive potential of demineralized bone matrix. Calcif Tissue Int. 1988;42:255-260.
10. Urist MR. Bone: formation by autoinduction. Science. 1965;150:893-899.
11. Dimitriou R, Giannoudis PV. Discovery and development of BMPs. Injury. 2005;36(Suppl 3):S28-S33.
12. Urist M, Strates B. The classics: bone morphogenetic protein. Clin Orthop Relat Res. 2009;462:3051-3062.
13. Pountos I, Panteli M, Georgouli T, et al. Neoplasia following use of BMPs: is there an increased risk? Expert Opin Drug Saf. 2014;13:1525-1534.
14. Rocque BG, Kelly MP, Miller JH, et al. Bone morphogenetic protein-associated complications in pediatric spinal fusion in the early postoperative period: an analysis of 4658 patients and review of the literature. J Neurosurg Pediatr. 2014;14:635-643.
15. Kelly MP, Savage JW, Bentzen SM, et al. Cancer risk from bone morphogenetic protein exposure in spinal arthrodesis. J Bone Joint Surg Am. 2014;96:1417-1422.
16. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966;16:381-390.
17. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211-228.
18. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279-4295.
19. Zuk PA. The adipose-derived stem cell: looking back and looking ahead. Mol Biol Cell. 2010;21:1783-1787.
20. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100:1249-1260.
21. Kuhbier JW, Weyand B, Radtke C, et al. Isolation, characterization, differentiation, and application of adipose-derived stem cells. Adv Biochem Eng Biotechnol. 2010;123:55-105.
22. Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109:1292-1298.
23. Fraser JK, Wulur I, Alfonso Z, et al. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol. 2006;24:150-154.
24. Liao HT, Chen CT. Osteogenic potential: Comparison between bone marrow and adipose-derived mesenchymal stem cells. World J Stem Cells. 2014;6:288-295.
25. Roberts TT, Rosenbaum AJ. Bone grafts, bone substitutes and orthobiologics: the bridge between basic science and clinical advancements in fracture healing. Organogenesis. 2012;8:114-124.
26. Dimitriou R, Jones E, McGonagle D, et al. Bone regeneration: current concepts and future directions. BMC Med. 2011;9:66.
27. Langenbach F, Naujoks C, Smeets R, et al. Scaffold-free microtissues: differences from monolayer cultures and their potential in bone tissue engineering. Clin Oral Investig. 2013;17:9-17.
28. Schubert T, Lafont S, Beaurin G, et al. Critical size bone defect reconstruction by an autologous 3D osteogenic-like tissue derived from differentiated adipose MSCs. Biomaterials. 2013;34:4428-4438.
29. Schubert T, Xhema D, Veřiter S, et al. The enhanced performance of bone allografts using osteogenic-differentiated adipose-derived mesenchymal stem cells. Biomaterials. 2011;32:8880-8891.
30. Schubert T, Poilvache H, Galli C, et al. Galactosyl-knock-out engineered pig as a xenogenic donor source of adipose MSCs for bone regeneration. Biomaterials. 2013;34:3279-3289.
31. Coleman SR. Structural fat grafts: the ideal filler? Clin Plast Surg. 2001;28:111-119.
32. Duhoux FP, Ameye G, Lambot V, et al. Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies. PLoS One. 2011;6:e26311.
33. Perrot P, Rousseau J, Bouffaut AL, et al. Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence. PLoS One. 2010;5:e10999.
34. Trobaugh-Lotrario AD, Kletzel M, Quinones RR, et al. Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT). Bone Marrow Transplant. 2005;35:143-149.
35. Meza-Zepeda LA, Noer A, Dahl JA, et al. High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. J Cell Mol Med. 2008;12:553-563.
36. Bernardo ME, Zaffaroni N, Novara F, et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res. 2007;67:9142-9149.
37. Roemeling-Van Rhijn M, De Klein A, Douben H, et al. Culture expansion induces non-tumorigenic aneuploidy in adipose tissuederived mesenchymal stromal cells. Cytotherapy. 2013;15:1352-1361.
38. Lafosse A, Desmet C, Aouassar N, et al. Autologous adipose stromal cells seeded on a human collagen matrix for dermal regeneration in chronic wounds: clinical proof of concept. Plast Reconstr Surg. 2015;136:195-279.
39. Rauch F, Schoenau E. Changes in bone density during childhood and adolescence: an approach based on bone's biological organization. J Bone Miner Res. 2001;16:597-604.
40. Granchi D, Devescovi V, Pratelli L, et al. Serum levels of fibroblast growth factor 2 in children with orthopedic diseases: potential role in predicting bone healing. J Orthop Res. 2013;31:249-256.